中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性肝癌的射频消融治疗

高恒军 陈敏山

引用本文:
Citation:

原发性肝癌的射频消融治疗

详细信息
  • 中图分类号: R735.7

Radiofrequency ablation for the treatment of hepatocellular carcinoma

  • 摘要: <正>原发性肝癌在我国是死亡率居第二位的恶性肿瘤,其治疗主要是以外科切除为主的多学科综合治疗模式。上世纪90年代兴起的射频消融(radiofrequen-cy ablation,RFA)近年来发展迅速,在肝癌综合治疗体系中发挥着重要作用,已在肝癌的临床治疗中得到广泛应用。RFA治疗肝癌的原理是通过射频产生热能,使局部达到高温而杀死肿瘤细胞。相对于其他局

     

  • [1]Lencioni RA, Allgaier HP, Cioni D, et al.Small hepatocellularcarcinoma in cirrhosis:randomized comparison of radio-fre-quency thermal ablation versus percutaneous ethanol injec-tion[J].Radiology, 2003, 228 (1) :235-240.
    [2]Rossi S, Di Stasi M, Buscarini E.Percutaneous RF interstitialthermal ablation in the treatment of hepatic cancer[J].AJRAm J Roentgenol, 1996, 167 (3) :759-768.
    [3]Tateishi R, Shiina S, Teratani T, et al.Percutaneous radio-frequency ablation for hepatocellular carcinoma—an analysisof 1000 cases[J].Cancer, 2005, 103 (6) :1201-1209.
    [4]陈敏山, 张耀军, 李锦清, 等.射频消融治疗肝脏恶性肿瘤的八年经验总结 (附803例报道) [J].中华外科杂志, 2007, 45 (21) :1469-1471.
    [5]Peng ZW, Zhang YJ, Chen MS, et al.Radiofrequency abla-tion as first-line treatment for small solitary hepatocellularcarcinoma:long-term results[J].Eur J Surg Oncol, 2010, 36 (11) :1054-1060.
    [6]Livraghi T, Solbiati L, Meloni MF, et al.Treatment of livertumors with percutaneous radio-frequency ablation:compli-cations encountered in a multicenter study[J].Radiofre-quency, 2003, 226 (2) :441-451.
    [7]梁惠宏, 陈敏山, 王旭东, 等.经皮射频消融治疗不同类型肝癌的疗效分析[J].中华肝脏病杂志, 2004, 12 (12) :756-757.
    [8] 中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组.肝癌射频消融治疗规范的专家共识[J].临床肝胆病杂志, 2011, 27 (3) :236-238.
    [9]Vivarelli M, Guglielmi A, Ruzzenete A, et al.Surgical resec-tion versus percutaneous radiofrequency ablation in the treat-ment of hepatocellular carcinoma on cirrhotic liver[J].AnnSurg, 2004, 240 (1) :102-107.
    [10]Huang J, Yan L, Cheng Z, et al.A randomized trial compa-ring radiofrequency ablation and surgical resection for HCCconforming to the Milan criteria[J].Ann Surg, 2010, 252 (6) :903-912.
    [11]Chen MS, Li JQ, Zheng Y, et al.A prospective randomizedtrial comparing percutaneous local ablative therapy and partialhepatectomy for small hepatocellular carcinoma[J].AnnSurg, 2006, 243 (3) :321-328.
    [12]Livraghi T, Meloni F, Di Stasi M, et al.Sustained completeresponse and complications rates after radiofrequency abla-tion of very early hepatocellular carcinoma in cirrhosis:Is re-section still the treatment of choice?[J]Hepatology, 2008, 47 (1) :82-89.
    [13]Lau WY, Lai EC.The current role of radiofrequency ablationin the management of hepatocellular carcinoma:a systematicreview[J].Ann Surg, 2009, 249 (1) :20-25.
    [14]Peng ZW, LinXJ, Zhang YJ, et al.Radiofrequency ablationvs.hepatic resection for the treatment of hepatocellular car-cinomas smaller than 2 cm:A retrospective comparativestudy[J].Radiology, 2012, 262 (3) :1022-1033.
    [15]Bruix J, Sherman M.AASLD practice guideline:manage-ment of hepatocellular carcinoma:an update (2010) [J].JHepatol, 2010, 53 (3) :1020-1022.
    [16]中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组.2009年原发性肝癌规范化诊治的专家共识[J].临床肿瘤学杂志, 2009, 14 (3) :259-269.
    [17]Peng ZW, Liang HH, Chen MS, et al.Conformal radiofre-quency ablation of hepatocellular carcinoma with a multi-pinbipolar system[J].J Surg Oncol, 2011, 103 (1) :69-74.
    [18]Peng ZW, Liang HH, Chen MS, et al.Percutaneous radio-frequency ablation for the treatment of hepatocellular carcino-mas in the caudate Lobe[J].Eur Surg Oncol, 2008, 34 (2) :166-172.
    [19]Liang HH, Chen MS, Peng ZW, et al.Percutaneous radio-frequency ablation versus repeat hepatectomy for recurrenthepatocellular carcinoma:a retrospective study[J].AnnSurg Oncol, 2008, 15 (12) :3484-3493.
    [20]Peng ZW, Zhang YJ, Liang HH, et al.Recurrent hepatocel-lular carcinoma treated with sequential transcatheter arterialchemoembolization and radiofrequency ablation versus radio-frequency ablation alone:a prospective randomized trial[J].Radiology, 2012, 262:689-700.
    [21]Zhang YJ, Liang HH, Chen MS, et al.Hepatocellular carci-noma treated with radiofrequency ablation with or withoutethanol injection:a prospective randomized trial[J].Radiolo-gy, 2007, 244 (2) :599-607.
    [22]高恒军, 梁惠宏, 陈敏山, 等.射频消融联合经导管肝动脉栓塞化疗治疗肝癌疗效分析[J].中华医学杂志, 2008, 88 (36) :2529-2532.
    [23]Ma HQ, Zhang YJ, Wang QJ, et al.Therapeutic safety andeffects of adjuvant autologous RetroNectin activated killer cellimmunotherapy for patients with primary hepatocellular carci-noma after radiofrequency ablation[J].Cancer Biol Ther, 2010, 9 (4) :1-5.
    [24]Llovet JM, S Ricci, Mazzaferro, et al.Sorafenib in advanced hep-atocellular carcinoma[J].N Engl J Med, 2008, 359 (4) :378-390.
  • 加载中
计量
  • 文章访问数:  3185
  • HTML全文浏览量:  7
  • PDF下载量:  740
  • 被引次数: 0
出版历程
  • 出版日期:  2012-04-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回